North Liberty, IA, United States of America

Kimberly Ann Lennox



Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Kimberly Ann Lennox

Introduction

Kimberly Ann Lennox is a notable inventor based in North Liberty, Iowa. She has made significant contributions to the field of biotechnology, particularly in the development of antisense compounds. Her work focuses on enhancing the stability and efficacy of nucleic acids, which are crucial for various therapeutic applications.

Latest Patents

Lennox holds a patent for "Modifications for antisense compounds." This invention pertains to modifications for antisense oligonucleotides, wherein the modifications are used to improve stability and provide protection from nuclease degradation. The modifications could also be incorporated into double-stranded nucleic acids, such as synthetic siRNAs and miRNAs. She has 1 patent to her name, showcasing her innovative approach in this specialized area.

Career Highlights

Throughout her career, Lennox has worked with prominent companies in the biotechnology sector. She has been associated with Integrated DNA Technologies, Inc., where she contributed to advancements in DNA synthesis and related technologies. Additionally, she has collaborated with Mark Aaron Behlke, further enhancing her expertise in the field.

Collaborations

Some of her notable coworkers include Mark Aaron Behlke and Ashley Mae Jacobi. Their collaborative efforts have played a significant role in advancing research and development in nucleic acid technologies.

Conclusion

Kimberly Ann Lennox's contributions to the field of biotechnology, particularly through her patent on antisense compounds, highlight her innovative spirit and dedication to improving therapeutic solutions. Her work continues to influence the landscape of genetic research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…